National Pharmaceutical Pricing Authority Current Affairs, GK & News

Price Monitoring and Resource Unit (PMRU) set up in Karnataka

The National Pharmaceutical Pricing Authority, in collaboration with the Karnataka State Drug Control Department, has launched the Price Monitoring and Resource Unit in the state. The PMRU will be mainly responsible for making access to medicine convenient for all the citizens of the state. Details of the PMRU The PMRU will have the first-ever governing ..

Month: 

Category: 

Topics: 

GoI regulates 24 classes of medical devices as drugs

On April 1, 2020, the National Pharmaceutical Pricing Authority revised the ceiling price of 883 scheduled formulations. The authority also informed that the disruption of supply of Active Pharmaceutical Ingredients are returning to normalcy. Highlights The NPPA has notified 24 classes of medical devices as drugs under Drugs and Cosmetics Act, 1940. The prices of ..

Month: 

Category: 

Topics: 

Govt. not to allow knee implants cost rise beyond 10% in a year

Government has notified that ceiling price of orthopaedic knee implants will be monitored to ensure that their cost does not increase beyond 10% in a given year. Background Earlier on 16 August 2017, National Pharmaceutical Pricing Authority (NPPA) notified ceiling price of orthopaedic knee implants by invoking extraordinary powers, in public interest, under Para 19 ..

Month: 

Topics: 

NPPA Slashes Prices of 9 Non-Scheduled Cancer Drugs

The National Pharmaceutical Pricing Authority (NPPA) has slashed the prices of 9 non-scheduled cancer drugs by up to 87 per cent as part of its efforts to bring down drugs prices. The move is expected to curb profiteering on these vital drugs and to make cancer cure affordable for patients and their families. National Pharmaceutical Pricing ..

Topics: 

NPPA reduces Prices of 9 Non-Scheduled Cancer Drugs by 87%

The National Pharmaceutical Pricing Authority (NPPA) has reduced the prices of 9 non-scheduled cancer drugs by up to 87%. This decision is in continuation of nodal agency’s efforts to bring down drugs prices. Key Facts Reason: In February 2019, the government had capped about 42 cancer drugs at 30%. This new anti-cancer non-scheduled medicine list ..

Month: 

Category: 

Topics: